The ranges of therapy duration until complete remission of oral mucositis were 2–4 days in the GM-CSF group and 5–8 days in the AA group. Therefore, topical GM-CSF was recommended for the treatment of chemotherapy-induced oral mucositis in patients with head and neck cancer. This evidence concerns the gene CSF2 and oral mucositis.